Clinical trials
ARDS (Moderate or Severe) clinical trials
Below are recruiting ards (moderate or severe) clinical trials, each written for real people, not researchers. We’re tracking 1,503 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06608381RecruitingPhase 3
Comparing partial vs. total omentectomy in gastric cancer surgery
This trial compares removing part or all of the fatty lining of the stomach (omentum) during minimally invasive surgery for a certain stage of gastric cancer. The goal is to see if removing less tissue is as safe and effective.
SeoulAges 20–85 - NCT06609447RecruitingPhase 4
Probiotic with vedolizumab for moderate ulcerative colitis
This study tests whether adding a special probiotic (VSL#3) to vedolizumab helps people with moderate ulcerative colitis more than vedolizumab alone. You may qualify if you are already planning to start vedolizumab and haven't responded well enough to other treatments.
Beijing, Beijing MunicipalityAges 18–85 - NCT06613880RecruitingPhase 2
Romiplostim with standard therapy for severe aplastic anemia
This trial tests combining a drug called romiplostim (a bone marrow stimulant) with standard immunosuppressive therapy as a first treatment for severe aplastic anemia. It aims to improve blood cell counts and reduce the need for transfusions.
Tianjin, Tianjin MunicipalityAges 12 years+ - NCT06618989Recruiting
Predicting serious bacterial infection in febrile infants
This trial is testing a new blood test to help doctors tell which babies under three months with fever are at risk for a serious bacterial infection. If successful, it could help avoid unnecessary antibiotics and hospital stays.
Paris, FranceAges 1 week–3 months - NCT06621394Recruiting
Mediterranean diet and mindful eating for depression and obesity
This study tests if a Mediterranean diet combined with mindful eating can help reduce depression severity in people who have both obesity and major depressive disorder. You would follow a special eating plan and learn mindfulness techniques to see if they improve your mood.
StuttgartAges 18 years+ - NCT06628011Recruiting
Digital exercise follow-up for mental health patients
This trial tests whether a digital follow-up program with aerobic interval training can help people with mental disorders. You will use an app called HelsaMi to track your progress.
TrondheimAges 18–65 - NCT06633328RecruitingEarly Phase 1
Cd7 car-t before stem cell transplant for severe aplastic anemia
This trial tests a new approach: first, you receive a specially engineered immune cell treatment (CD7 CAR-T) to help prepare your body, then a stem cell transplant from a relative. It's designed for people with severe aplastic anemia who cannot have or choose not to get a standard transplant.
Hanzhou, ZhejiangAges Any age - NCT06643312Recruiting
Treadmill training with spinal stimulation for standing after spinal cord injury
This trial tests whether combining treadmill training with spinal cord stimulation (TPAD) can help people with severe spinal cord injuries regain the ability to stand. It aims to improve standing function and may lead to better recovery.
West Orange, New JerseyAges 18 years+ - NCT06645821RecruitingEarly Phase 1
Cream for mild to moderate hidradenitis suppurativa
This trial tests a new cream (EVO101) for people with mild to moderate hidradenitis suppurativa (HS), a skin condition causing painful lumps. It aims to see if the cream can reduce the number of lesions. Participants cannot use certain other HS treatments during the study.
Norfolk, VirginiaAges 18 years+ - NCT06647134Recruiting
Understanding how immunotherapy side effects affect daily life
This study is for people whose immunotherapy (a type of cancer treatment) caused joint pain, swelling, or muscle stiffness. Researchers want to talk to you about how these side effects have affected your life, so they can better understand and help others in the future.
Houston, TexasAges 18 years+ - NCT06647979RecruitingPhase 1
Gene editing for severe sickle cell or thalassemia
This trial tests a new gene therapy that edits your own blood stem cells to help them make more fetal hemoglobin, which can prevent sickling and reduce the need for transfusions. It is for people with severe sickle cell disease or beta thalassemia who do not have a matched sibling donor.
Boston, MassachusettsAges 13–40 - NCT06650137Recruiting
Using Diaphragm Ultrasound to Find the Cause of Breathing Trouble
This study tests if ultrasound of your diaphragm (the muscle that helps you breathe) can help doctors find the cause of sudden breathing trouble. It may help patients who come to the emergency room with fast or difficult breathing and low oxygen levels.
Nîmes, GardAges 18 years+ - NCT06651255Recruiting
Algorithm-guided care for bleeding in Von Willebrand disease
This trial tests whether a special algorithm can reduce repeat bleeding from the gut or nose in people with inherited Von Willebrand disease. If you have had serious nosebleeds or digestive bleeding, this study may help find a better way to manage your condition.
Lille, NordAges 18 years+ - NCT06659211Recruiting
Mentalization-based therapy for mental health challenges
This study tests whether mentalization-based therapy (MBT), a type of talk therapy that helps you understand your own and others' thoughts and feelings, can improve severe long-term mental health symptoms and relationship difficulties. You will be placed in either MBT or the usual care (TAU) group to compare results.
OuluAges 18–64 - NCT06659588Recruiting
Study of chronic hepatitis risk in people with immune weaknesses
This study looks at people with certain immune system weaknesses to see if they are at risk for chronic hepatitis caused by a virus in the gut. Researchers want to understand how the immune system affects this infection.
ParisAges Any age - NCT06660693RecruitingPhase 3
Comparing rescue treatments for severe ulcerative colitis flare
This trial tests two different medicines, infliximab and upadacitinib, to see which works better for people with severe ulcerative colitis that hasn't improved after 3 days of IV steroids. The goal is to find the best rescue option to help you feel better and avoid surgery.
Hamilton, OntarioAges 18–64 - NCT06667700RecruitingPhase 3
A study of the antiviral molnupiravir for high-risk people with COVID-19
This study tests an antiviral pill called molnupiravir to see if it can prevent severe COVID-19 in people who are at high risk and cannot take Paxlovid. If you have mild to moderate COVID-19 symptoms and certain health risks, you may be able to join.
Cullman, AlabamaAges 18 years+ - NCT06668623Recruiting
Reiki for nerve pain and sleep in diabetic neuropathy
This trial tests if Reiki, a gentle hands-on energy therapy, can reduce nerve pain and improve sleep in people with diabetic neuropathy. It may offer a non-drug option for managing symptoms.
Kayseri, KocasinanAges 18–70 - NCT06668649Recruiting
Polish fatigue scale study for MS, ALS, or stroke
This study tests a Polish version of a scale that measures how tired people feel. It's for people with MS, ALS, or stroke, or healthy volunteers.
Krakow, Lesser Poland VoivodeshipAges 18 years+ - NCT06669897Recruiting
Cough severity questionnaire study
This study is testing a new questionnaire to measure how severe a cough is. It is looking for people with a chronic cough (cough lasting a long time) and healthy volunteers to see if the questionnaire works well.
Badalona, BarcelonaAges 30–99 - NCT06670248Recruiting
Study of blood vessel health during burn surgery
This trial looks at how a protective layer inside your blood vessels (called the glycocalyx) responds during surgery to remove burned skin. The goal is to improve care for people with major burns.
Barcelona, SpainAges 18 years+ - NCT06675448Recruiting
Best practices for heart failure with leaky mitral valve
This trial compares two treatment approaches for people with heart failure and a leaky mitral valve (mitral regurgitation). It aims to find which strategy leads to better outcomes. You may be eligible if your heart function is reduced and you have symptoms despite standard treatments.
Falls Church, VirginiaAges 18–99 - NCT06675539Recruiting
Testing a tool to predict alcohol withdrawal severity in French speakers
This study tests a French version of a questionnaire (PAWSS) that helps doctors predict how severe alcohol withdrawal might be. It is for people aged 18 to 60 who are dependent on alcohol and planning a supervised detox or being hospitalized for another reason.
ÉtampesAges 18–60 - NCT06678594Recruiting
A standardized method for treating hardened heart artery blockages
This trial is testing a new step-by-step approach (algorithm) to treat hardened, calcified blockages in heart arteries during a stent procedure. The goal is to see if this standardized method helps improve outcomes for patients with these tough-to-treat blockages.
DublinAges 18 years+
Hear when a new ARDS (Moderate or Severe) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for ards (moderate or severe)?
- Yes. Clin2 currently lists 1,503 recruiting ards (moderate or severe) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a ards (moderate or severe) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a ards (moderate or severe) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.